RESUMEN
Revaluation of syndrome therapeutic effect of post-marketing Chinese materia medica (CMM) is a necessary complement to pre-ipo syndrome therapeutic effect evaluation. With the transition of research stage and research target, the evaluation method needs a breakthrough and innovation. So considering the academic characteristics of syndrome theory of traditional Chinese medicine (TCM), concerning the key link in the process of design and implementation in syndrome curative effect evaluation, and analyzing the common problems in syndrome curative effect evaluation are the urgent needs to change the current syndrome curative effect evaluation. Through analyzing the type and level of efficacy evaluation in TCM and interpreting the current situation and demand of syndrome therapeutic effect revaluation for post-marketing CMM, here this paper tried to put forward the research of revaluation of syndrome therapeutic effect for post-marketing CMM, which involved in research of symptoms unit, expression of specification symptoms, and symptoms of selection and optimization. Then drawing lessons from study design with effective registration and combining the concept of causality research could list some inspiration for how to establish the syndrome therapeutic effect revaluation for post-marketing CMM.